melanoma |
MacConaill et al., 2014, J Mol Diagn |
Oncomap Variants (View variants) |
likely pathogenic |
|
hepatocellular carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
uterine corpus endometrial carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
medulloblastoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
prostate adenocarcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
skin melanoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
cervix carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
gastric adenocarcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
urinary bladder urothelial carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|